Rising Use of Percutaneous Ventricular Assist Devices: What Can Be Learned From the Data?-Reference-Cited by-同舟云学术

Rising Use of Percutaneous Ventricular Assist Devices: What Can Be Learned From the Data?

Published:2022-08 Issue:8 Volume:15 Page:
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ: Cardiovascular Interventions

Author:

Almarzooq Zaid I.¹²^ORCID,Yeh Robert W.¹³^ORCID

Affiliation:

1. Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center, Boston, MA (Z.I.A., R.W.Y.).

2. Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, MA (Z.I.A.).

3. Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. The US Food and Drug Administration 515 Program Initiative

2. A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention

3. PMA P140003: FDA Summary of Safety and Effectiveness Data [Internet]. US Food and Drug Administration. Accessed June 20, 2022. https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140003B.pdf.

4. National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock

5. Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of timing of percutaneous left ventricular assist device insertion with outcomes in patients undergoing cardiac surgery;JTCVS Open;2023-12